Table: Fractale -2021/22 group results

ADR Biomedical Holdings

13/05/2022 08:00

May 13 (Reuters)- 
          Fractale Corporation 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended       Year ended       Year to       NEXT   
              Mar 31, 2022     Mar 31, 2021   Mar 31, 2023     YEAR     
                 LATEST          YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales           1.34             1.39           3.26                  
               (-3.8 pct)      (+17.6 pct)    (+144.1 pct)              
  Operating   loss 462 mln     loss 731 mln      320 mln                
  Recurring   loss 418 mln     loss 745 mln      140 mln                
  Net
  Net          loss 77 mln     loss 831 mln      20 mln                 
  EPS         loss 8.79 yen  loss 101.64 yen    2.24 yen                
  Ann Div          NIL             NIL                                  
  -Q2 Div          NIL             NIL                                  
  -Q4 Div          NIL             NIL                                  
  
  NOTE - Fractale Corporation.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3750.T